101 related articles for article (PubMed ID: 27275853)
1. Immediate postoperative evaluation of enteric anastomosis after the use of meloxicam in rats.
Sousa EL; Wouk AF; Malafaia O; Ribas-Filho JM; Noronha L; Cirio SM; PimpãoVII CT; Marinho CH; Torres MF; Graça YL; Ferrarin DD
Acta Cir Bras; 2016 May; 31(5):320-6. PubMed ID: 27275853
[TBL] [Abstract][Full Text] [Related]
2. Effect of aluminum oxide-blasted implant surface on the bone healing around implants in rats submitted to continuous administration of selective cyclooxygenase-2 inhibitors.
Ribeiro FV; Nociti FH; Sallum EA; Casati MZ
Int J Oral Maxillofac Implants; 2009; 24(2):226-33. PubMed ID: 19492637
[TBL] [Abstract][Full Text] [Related]
3. Meloxicam temporally inhibits the expression of vascular endothelial growth factor receptor (VEGFR)-1 and VEGFR-2 during alveolar bone repair in rats.
Arantes RV; Cestari TM; Viscelli BA; Dionísio TJ; Garlet GP; Santos CF; de Assis GF; Taga R
J Periodontol; 2015 Jan; 86(1):162-72. PubMed ID: 25327303
[TBL] [Abstract][Full Text] [Related]
4. Selective cyclo-oxygenase 2 inhibition affects ileal but not colonic anastomotic healing in the early postoperative period.
de Hingh IH; van Goor H; de Man BM; Lomme RM; Bleichrodt RP; Hendriks T
Br J Surg; 2006 Apr; 93(4):489-97. PubMed ID: 16521174
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral administration of meloxicam prior to transport on inflammatory mediators and leukoctye function of cattle at feedlot arrival.
Capik SF; White BJ; Larson RL; Van Engen N; Cernicchiaro N; Engelken TJ; Lakritz J; Ballou MA; Hulbert LE; Vann RC; Caswell JL; Jacob G; Carroll JA; Coetzee JF
Am J Vet Res; 2017 Dec; 78(12):1426-1436. PubMed ID: 29182392
[TBL] [Abstract][Full Text] [Related]
6. Selective COX-2 inhibitor reduces bone healing in bone defects.
Gurgel BC; Ribeiro FV; Silva MA; Nociti FH; Sallum AW; Sallum EA; Toledo Sd; Casati MZ
Braz Oral Res; 2005; 19(4):312-6. PubMed ID: 16491262
[TBL] [Abstract][Full Text] [Related]
7. Hyperfibrinogenemia in rats treated with meloxicam.
Moya M; Campana V; Gavotto A; Spitale L; Simes J; Palma J
Jpn Heart J; 2002 Sep; 43(5):559-66. PubMed ID: 12452313
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model.
Quintana R; Kopcow L; Marconi G; Young E; Yovanovich C; Paz DA
Fertil Steril; 2008 Oct; 90(4 Suppl):1511-6. PubMed ID: 18166186
[TBL] [Abstract][Full Text] [Related]
9. Postoperative non-steroidal anti-inflammatory drugs and colorectal anastomotic leakage. NSAIDs and anastomotic leakage.
Klein M
Dan Med J; 2012 Mar; 59(3):B4420. PubMed ID: 22381097
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-level laser therapy on inflammatory reactions during wound healing: comparison with meloxicam.
Viegas VN; Abreu ME; Viezzer C; Machado DC; Filho MS; Silva DN; Pagnoncelli RM
Photomed Laser Surg; 2007 Dec; 25(6):467-73. PubMed ID: 18158747
[TBL] [Abstract][Full Text] [Related]
11. Timing matters: NSAIDs interfere with the late proliferation stage of a repaired rotator cuff tendon healing in rats.
Chechik O; Dolkart O; Mozes G; Rak O; Alhajajra F; Maman E
Arch Orthop Trauma Surg; 2014 Apr; 134(4):515-20. PubMed ID: 24474613
[TBL] [Abstract][Full Text] [Related]
12. Effects of meloxicam and indomethacin on cyclooxygenase pathways in healthy volunteers.
Stichtenoth DO; Wagner B; Frölich JC
J Investig Med; 1997 Feb; 45(2):44-9. PubMed ID: 9084574
[TBL] [Abstract][Full Text] [Related]
13. The effect of meloxicam, a selective COX-2 inhibitor, on the microvasculature of small metastatic liver tumors in rats.
Iwase N; Higuchi T; Gonda T; Kobayashi H; Uetake H; Enomoto M; Sugihara K
Jpn J Clin Oncol; 2007 Sep; 37(9):673-8. PubMed ID: 17725981
[TBL] [Abstract][Full Text] [Related]
14. The effect of meloxicam and deendothelisation on vascular responses in the rabbit renal and ear arteries.
Fackovcova D; Vojtko R; Kristova V; Kurtansky A
Bratisl Lek Listy; 2004; 105(1):3-7. PubMed ID: 15141807
[TBL] [Abstract][Full Text] [Related]
15. Meloxicam, 15 mg/day, spares platelet function in healthy volunteers.
de Meijer A; Vollaard H; de Metz M; Verbruggen B; Thomas C; Novakova I
Clin Pharmacol Ther; 1999 Oct; 66(4):425-30. PubMed ID: 10546927
[TBL] [Abstract][Full Text] [Related]
16. Anastomotic healing in a rat model of peritonitis after non-steroidal anti-inflammatory drug administration.
Ghiselli R; Lucarini G; Ortenzi M; Salvolini E; Saccomanno S; Orlando F; Provinciali M; Casciani F; Guerrieri M
Eur J Histochem; 2020 Jan; 64(1):. PubMed ID: 31941266
[TBL] [Abstract][Full Text] [Related]
17. Renal effect of meloxicam versus ketoprofen in anaesthetized pseudo-normovolaemic piglets.
Junot S; Troncy E; Keroack S; Gauvin D; del Castillo JR; Boivin R; Bonnet JM
Can J Physiol Pharmacol; 2008; 86(1-2):55-63. PubMed ID: 18418447
[TBL] [Abstract][Full Text] [Related]
18. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
19. Exercise-induced apoptosis of rat skeletal muscle and the effect of meloxicam.
Arslan S; Erdem S; Sivri A; Hasçelik Z; Tan E
Rheumatol Int; 2002 Jan; 21(4):133-6. PubMed ID: 11843167
[TBL] [Abstract][Full Text] [Related]
20. COX-2 inhibition decreases VEGF expression and alveolar bone loss during the progression of experimental periodontitis in rats.
Oliveira TM; Sakai VT; Machado MA; Dionísio TJ; Cestari TM; Taga R; Amaral SL; Santos CF
J Periodontol; 2008 Jun; 79(6):1062-9. PubMed ID: 18533784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
